$ABT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ABBOTT LABORATORIES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ABBOTT LABORATORIES. Get notifications about new insider transactions in ABBOTT LABORATORIES for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 53 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.55 | 400 | 21,818 | 3,302,008 | 3.3 M to 3.3 M (-0.01 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.54 | 1,200 | 65,448 | 3,302,408 | 3.3 M to 3.3 M (-0.04 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.54 | 800 | 43,628 | 3,303,608 | 3.3 M to 3.3 M (-0.02 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.53 | 7,300 | 398,069 | 3,304,408 | 3.3 M to 3.3 M (-0.22 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.53 | 1,799 | 98,090 | 3,311,708 | 3.3 M to 3.3 M (-0.05 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.52 | 3,200 | 174,464 | 3,313,507 | 3.3 M to 3.3 M (-0.10 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.52 | 100 | 5,452 | 3,316,707 | 3.3 M to 3.3 M (0.00 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.52 | 607 | 33,091 | 3,316,807 | 3.3 M to 3.3 M (-0.02 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.51 | 6,600 | 359,766 | 3,317,414 | 3.3 M to 3.3 M (-0.20 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.51 | 1,882 | 102,578 | 3,324,014 | 3.3 M to 3.3 M (-0.06 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.50 | 10,892 | 593,614 | 3,325,896 | 3.3 M to 3.3 M (-0.33 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.50 | 100 | 5,450 | 3,336,788 | 3.3 M to 3.3 M (0.00 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.50 | 6,289 | 342,719 | 3,336,888 | 3.3 M to 3.3 M (-0.19 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.49 | 10,800 | 588,492 | 3,343,177 | 3.4 M to 3.3 M (-0.32 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.49 | 5,184 | 282,450 | 3,353,977 | 3.4 M to 3.4 M (-0.15 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.48 | 12,711 | 692,495 | 3,359,161 | 3.4 M to 3.4 M (-0.38 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.48 | 2,500 | 136,188 | 3,371,872 | 3.4 M to 3.4 M (-0.07 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.47 | 7,436 | 405,039 | 3,374,372 | 3.4 M to 3.4 M (-0.22 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.47 | 1,359 | 74,018 | 3,381,808 | 3.4 M to 3.4 M (-0.04 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.46 | 17,860 | 972,656 | 3,383,167 | 3.4 M to 3.4 M (-0.53 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Option Exercise | M | 26.70 | 530,000 | 14,149,569 | 0 | |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.46 | 2,377 | 129,440 | 3,401,027 | 3.4 M to 3.4 M (-0.07 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.45 | 13,800 | 751,410 | 3,403,404 | 3.4 M to 3.4 M (-0.40 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.45 | 3,501 | 190,612 | 3,417,204 | 3.4 M to 3.4 M (-0.10 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.44 | 9,150 | 498,126 | 3,420,705 | 3.4 M to 3.4 M (-0.27 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.44 | 10,833 | 589,694 | 3,429,855 | 3.4 M to 3.4 M (-0.31 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.43 | 19,665 | 1,070,366 | 3,440,688 | 3.5 M to 3.4 M (-0.57 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.43 | 21,402 | 1,164,804 | 3,460,353 | 3.5 M to 3.5 M (-0.61 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.42 | 39,699 | 2,160,420 | 3,481,755 | 3.5 M to 3.5 M (-1.13 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.42 | 100 | 5,442 | 3,521,454 | 3.5 M to 3.5 M (0.00 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.42 | 8,167 | 444,407 | 3,521,554 | 3.5 M to 3.5 M (-0.23 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.41 | 24,651 | 1,341,261 | 3,529,721 | 3.6 M to 3.5 M (-0.69 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.41 | 100 | 5,441 | 3,554,372 | 3.6 M to 3.6 M (0.00 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.41 | 14,181 | 771,517 | 3,554,472 | 3.6 M to 3.6 M (-0.40 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.40 | 19,900 | 1,082,560 | 3,568,653 | 3.6 M to 3.6 M (-0.55 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.40 | 100 | 5,440 | 3,588,553 | 3.6 M to 3.6 M (0.00 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.40 | 5,435 | 295,637 | 3,588,653 | 3.6 M to 3.6 M (-0.15 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.39 | 27,636 | 1,503,122 | 3,594,088 | 3.6 M to 3.6 M (-0.76 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.39 | 8,502 | 462,381 | 3,621,724 | 3.6 M to 3.6 M (-0.23 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.38 | 16,446 | 894,333 | 3,630,226 | 3.6 M to 3.6 M (-0.45 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.38 | 5,199 | 282,696 | 3,646,672 | 3.7 M to 3.6 M (-0.14 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.37 | 8,035 | 436,863 | 3,651,871 | 3.7 M to 3.7 M (-0.22 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.37 | 2,407 | 130,857 | 3,659,906 | 3.7 M to 3.7 M (-0.07 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.36 | 7,450 | 404,982 | 3,662,313 | 3.7 M to 3.7 M (-0.20 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.36 | 2,650 | 144,041 | 3,669,763 | 3.7 M to 3.7 M (-0.07 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.35 | 800 | 43,480 | 3,672,413 | 3.7 M to 3.7 M (-0.02 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.35 | 300 | 16,304 | 3,673,213 | 3.7 M to 3.7 M (-0.01 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.34 | 1,000 | 54,340 | 3,673,513 | 3.7 M to 3.7 M (-0.03 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.33 | 2,800 | 152,124 | 3,674,513 | 3.7 M to 3.7 M (-0.08 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Sell | S | 54.33 | 600 | 32,595 | 3,677,313 | 3.7 M to 3.7 M (-0.02 %) |
Dec 08 2017 | ABT | ABBOTT LABORATORIE ... | WHITE MILES D | Chairman and CEO | Buy | M | 26.70 | 530,000 | 14,149,569 | 3,677,913 | 3.1 M to 3.7 M (+16.84 %) |
Dec 01 2017 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 56.13 | 600 | 33,675 | 25,018 | 25.6 K to 25 K (-2.34 %) |
Dec 01 2017 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 56.12 | 1,588 | 89,120 | 25,618 | 27.2 K to 25.6 K (-5.84 %) |
Nov 22 2017 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Sell | S | 55.87 | 453 | 25,307 | 8,803 | 9.3 K to 8.8 K (-4.89 %) |
Nov 22 2017 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Sell | S | 55.86 | 1,000 | 55,861 | 9,256 | 10.3 K to 9.3 K (-9.75 %) |
Nov 22 2017 | ABT | ABBOTT LABORATORIE ... | Wellisch Alejandro D | Senior Vice Preside ... | Sell | S | 55.86 | 700 | 39,102 | 10,256 | 11 K to 10.3 K (-6.39 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 23.23 | 6,333 | 147,103 | 0 | |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Option Exercise | M | 26.19 | 3,233 | 84,665 | 0 | |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.54 | 10,287 | 571,289 | 128,854 | 139.1 K to 128.9 K (-7.39 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.53 | 200 | 11,106 | 139,141 | 139.3 K to 139.1 K (-0.14 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.53 | 200 | 11,106 | 139,341 | 139.5 K to 139.3 K (-0.14 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.53 | 713 | 39,594 | 139,541 | 140.3 K to 139.5 K (-0.51 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.53 | 900 | 49,977 | 140,254 | 141.2 K to 140.3 K (-0.64 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.53 | 2,000 | 111,060 | 141,154 | 143.2 K to 141.2 K (-1.40 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.57 | 1,922 | 106,796 | 143,154 | 145.1 K to 143.2 K (-1.32 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.57 | 3,944 | 219,168 | 145,076 | 149 K to 145.1 K (-2.65 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.57 | 1,000 | 55,571 | 149,020 | 150 K to 149 K (-0.67 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 55.58 | 2,700 | 150,053 | 150,020 | 152.7 K to 150 K (-1.77 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 23.23 | 6,333 | 147,103 | 152,720 | 146.4 K to 152.7 K (+4.33 %) |
Nov 20 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Buy | M | 26.19 | 3,233 | 84,665 | 146,387 | 143.2 K to 146.4 K (+2.26 %) |
Nov 16 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 38.40 | 71,157 | 2,732,429 | 142,313 | |
Nov 16 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 55.00 | 71,157 | 3,913,635 | 73,798 | 145 K to 73.8 K (-49.09 %) |
Nov 16 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 38.40 | 71,157 | 2,732,429 | 144,955 | 73.8 K to 145 K (+96.42 %) |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 28,319 | 1,330,993 | 70,798 | |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 42.08 | 34,142 | 1,436,695 | 0 | |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 42.08 | 34,142 | 1,436,695 | 34,142 | |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 56.21 | 96,603 | 5,430,055 | 73,798 | 170.4 K to 73.8 K (-56.69 %) |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 28,319 | 1,330,993 | 170,401 | 142.1 K to 170.4 K (+19.93 %) |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 42.08 | 68,284 | 2,873,391 | 142,082 | 73.8 K to 142.1 K (+92.53 %) |
Oct 03 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 147 | 0 | 6,502 | |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | M | 47.00 | 28,319 | 1,330,993 | 99,117 | |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | M | 42.08 | 34,141 | 1,436,653 | 68,284 | |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Payment of Exercise | F | 52.61 | 5,487 | 288,671 | 73,798 | 79.3 K to 73.8 K (-6.92 %) |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 52.95 | 62,460 | 3,307,257 | 79,285 | 141.7 K to 79.3 K (-44.07 %) |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Buy | M | 47.00 | 28,319 | 1,330,993 | 141,745 | 113.4 K to 141.7 K (+24.97 %) |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Buy | M | 42.08 | 34,141 | 1,436,653 | 113,426 | 79.3 K to 113.4 K (+43.06 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 27.03 | 22,000 | 594,739 | 0 | |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 22.39 | 17,300 | 387,380 | 0 | |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Option Exercise | M | 26.19 | 13,400 | 350,918 | 0 | |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 52.04 | 1,200 | 62,449 | 45,339 | 46.5 K to 45.3 K (-2.58 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 52.04 | 1,200 | 62,448 | 46,539 | 47.7 K to 46.5 K (-2.51 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 52.03 | 500 | 26,015 | 47,739 | 48.2 K to 47.7 K (-1.04 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 52.03 | 200 | 10,405 | 48,239 | 48.4 K to 48.2 K (-0.41 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 52.02 | 1,600 | 83,232 | 48,439 | 50 K to 48.4 K (-3.20 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 52.01 | 3,816 | 198,470 | 50,039 | 53.9 K to 50 K (-7.09 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 52.00 | 1,109 | 57,668 | 53,855 | 55 K to 53.9 K (-2.02 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 51.99 | 909 | 47,259 | 54,964 | 55.9 K to 55 K (-1.63 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 51.98 | 1,913 | 99,438 | 55,873 | 57.8 K to 55.9 K (-3.31 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 51.97 | 1,701 | 88,401 | 57,786 | 59.5 K to 57.8 K (-2.86 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 51.96 | 4,152 | 215,738 | 59,487 | 63.6 K to 59.5 K (-6.52 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Sell | S | 51.95 | 34,400 | 1,787,080 | 63,639 | 98 K to 63.6 K (-35.09 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 27.03 | 22,000 | 594,739 | 98,039 | 76 K to 98 K (+28.93 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 22.39 | 17,300 | 387,380 | 76,039 | 58.7 K to 76 K (+29.45 %) |
Sep 26 2017 | ABT | ABBOTT LABORATORIE ... | Contreras Jaime | Senior Vice Preside ... | Buy | M | 26.19 | 13,400 | 350,918 | 58,739 | 45.3 K to 58.7 K (+29.56 %) |
Aug 22 2017 | ABT | ABBOTT LABORATORIE ... | LIDDY EDWARD M | Director | Buy | P | 48.96 | 1,185 | 58,012 | 22,967 | 21.8 K to 23 K (+5.44 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 27.03 | 44,000 | 1,189,478 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 22.39 | 45,800 | 1,025,549 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.19 | 28,700 | 751,593 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.02 | 38,700 | 1,006,781 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Option Exercise | M | 26.70 | 39,350 | 1,050,539 | 0 | |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Sell | S | 49.50 | 196,550 | 9,729,225 | 182,138 | 378.7 K to 182.1 K (-51.90 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 27.03 | 44,000 | 1,189,478 | 378,688 | 334.7 K to 378.7 K (+13.15 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 22.39 | 45,800 | 1,025,549 | 334,688 | 288.9 K to 334.7 K (+15.85 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.19 | 28,700 | 751,593 | 288,888 | 260.2 K to 288.9 K (+11.03 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.02 | 38,700 | 1,006,781 | 260,188 | 221.5 K to 260.2 K (+17.47 %) |
Aug 18 2017 | ABT | ABBOTT LABORATORIE ... | Fussell Stephen R | Executive Vice Pres ... | Buy | M | 26.70 | 39,350 | 1,050,539 | 221,488 | 182.1 K to 221.5 K (+21.60 %) |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Option Exercise | M | 33.14 | 336,131 | 11,139,381 | 0 | |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Option Exercise | M | 28.50 | 168,413 | 4,799,771 | 0 | |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | M | 33.14 | 336,131 | 11,139,381 | 6,943,248 | 6.6 M to 6.9 M (+5.09 %) |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | M | 28.50 | 168,413 | 4,799,771 | 6,607,117 | 6.4 M to 6.6 M (+2.62 %) |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 49.16 | 1,000 | 49,161 | 27,206 | 28.2 K to 27.2 K (-3.55 %) |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 49.16 | 600 | 29,496 | 28,206 | 28.8 K to 28.2 K (-2.08 %) |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Sell | S | 49.17 | 400 | 19,666 | 28,806 | 29.2 K to 28.8 K (-1.37 %) |
Jul 28 2017 | ABT | ABBOTT LABORATORIE ... | Blaser Brian J | Executive Vice Pres ... | Sell | S | 50.00 | 15,000 | 750,000 | 143,154 | 158.2 K to 143.2 K (-9.48 %) |
Jul 27 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Option Exercise | M | 26.70 | 4,600 | 122,808 | 0 | |
Jul 27 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Sell | S | 50.79 | 200 | 10,158 | 100,879 | 101.1 K to 100.9 K (-0.20 %) |
Jul 27 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Sell | S | 50.79 | 1,800 | 91,422 | 101,079 | 102.9 K to 101.1 K (-1.75 %) |
Jul 27 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Sell | S | 50.80 | 2,600 | 132,067 | 102,879 | 105.5 K to 102.9 K (-2.46 %) |
Jul 27 2017 | ABT | ABBOTT LABORATORIE ... | ALLEN HUBERT L | Executive Vice Pres ... | Buy | M | 26.70 | 4,600 | 122,808 | 105,479 | 100.9 K to 105.5 K (+4.56 %) |
Jul 26 2017 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Option Exercise | A | 50.74 | 69,024 | 3,502,278 | 69,024 | |
Jul 26 2017 | ABT | ABBOTT LABORATORIE ... | BRYNELSEN CHARLES | Senior Vice Preside ... | Grant | A | 0.00 | 9,980 | 0 | 9,980 | 0 to 10 K |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Payment of Exercise | F | 50.84 | 1,524 | 77,480 | 517,046 | 518.6 K to 517 K (-0.29 %) |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | Fain Eric S | Senior Vice Preside ... | Payment of Exercise | F | 50.85 | 26,488 | 1,346,915 | 518,570 | 545.1 K to 518.6 K (-4.86 %) |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Option Exercise | A | 50.72 | 69,024 | 3,500,897 | 69,024 | |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Grant | A | 0.00 | 10,000 | 0 | 66,187 | 56.2 K to 66.2 K (+17.80 %) |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | PEDERSON MICHAEL J | Senior Vice Preside ... | Grant | A | 0.00 | 6,028 | 0 | 56,187 | 50.2 K to 56.2 K (+12.02 %) |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | A | 50.72 | 49,611 | 2,516,270 | 49,611 | |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Grant | A | 0.00 | 7,173 | 0 | 79,285 | 72.1 K to 79.3 K (+9.95 %) |
Jul 12 2017 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Option Exercise | A | 48.34 | 35,730 | 1,727,188 | 35,730 | |
Jul 12 2017 | ABT | ABBOTT LABORATORIE ... | Bracken Sharon J | Senior Vice Preside ... | Grant | A | 0.00 | 5,167 | 0 | 29,206 | 24 K to 29.2 K (+21.49 %) |
Jul 11 2017 | ABT | ABBOTT LABORATORIE ... | ROUSSEAU MICHAEL T | Pres., Cardiovas. & ... | Payment of Exercise | F | 48.44 | 3,288 | 159,271 | 183,116 | 186.4 K to 183.1 K (-1.76 %) |
Jul 06 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Payment of Exercise | F | 48.71 | 24,236 | 1,180,536 | 6,438,704 | 6.5 M to 6.4 M (-0.37 %) |
Jul 05 2017 | ABT | ABBOTT LABORATORIE ... | Mason Heather L | Executive Vice Pres ... | Payment of Exercise | F | 48.61 | 613 | 29,798 | 59,064 | 59.7 K to 59.1 K (-1.03 %) |
Jul 05 2017 | ABT | ABBOTT LABORATORIE ... | Ford Robert B | Executive Vice Pres ... | Payment of Exercise | F | 48.61 | 1,618 | 78,651 | 52,166 | 53.8 K to 52.2 K (-3.01 %) |
Jul 05 2017 | ABT | ABBOTT LABORATORIE ... | Alpern Robert J | Director | Option Exercise | A | 0.00 | 162 | 0 | 6,320 | |
Jul 05 2017 | ABT | ABBOTT LABORATORIE ... | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 678 | 0 | 30,120 | |
Jun 16 2017 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 47.98 | 300 | 14,393 | 46,538 | 46.8 K to 46.5 K (-0.64 %) |
Jun 16 2017 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 47.97 | 152 | 7,292 | 46,838 | 47 K to 46.8 K (-0.32 %) |
Jun 16 2017 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Sell | S | 47.98 | 100 | 4,798 | 46,990 | 47.1 K to 47 K (-0.21 %) |
Jun 16 2017 | ABT | ABBOTT LABORATORIE ... | Watkin Jared | Senior Vice Preside ... | Payment of Exercise | F | 47.64 | 1,421 | 67,696 | 47,090 | 48.5 K to 47.1 K (-2.93 %) |